Jonas Wixner
Impact in
- Nephrology top 5%
- Parathyroid Disorders and Treatments
-
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Protein Kinase Regulation and GTPase Signaling
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 36
- Protein Kinase Regulation and GTPase Signaling 3
- Epidemiology 10
- Neuroendocrine Tumor Research Advances 7
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Co-authors
- Intissar Anan (22 shared papers)Ole B. Suhr (16 shared papers)Pontus Karling (9 shared papers)Konen Obayashi (2 shared papers)Björn Pilebro (11 shared papers)Sadahisa Okamoto (2 shared papers)Styrbjörn Friman (1 shared paper)Bo-Göran Ericzon (1 shared paper)
- Journals
- Amyloid (11 papers)Orphanet Journal of Rare Diseases (3 papers)Neurogastroenterology & Motility (2 papers)PLoS ONE (2 papers)Scandinavian Journal of Clinical and Laboratory Investigation (1 paper)
- Partner nations
- SwedenUnited StatesItaly
In The Last Decade
Jonas Wixner
36 papers receiving 534 citations
Peers
Comparison fields: 5 of 54
- Nephrology 89
- Molecular Biology 471
- Genetics 38
- Rheumatology 49
- Cell Biology 47
Countries citing papers authored by Jonas Wixner
This map shows the geographic impact of Jonas Wixner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Wixner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Wixner more than expected).
Fields of papers citing papers by Jonas Wixner
This network shows the impact of papers produced by Jonas Wixner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Wixner. The network helps show where Jonas Wixner may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonas Wixner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 100 | |
| 2 | 2014 | 74 | |
| 3 | 2022 | 40 | |
| 4 | 2020 | 31 | |
| 5 | 2012 | 22 | |
| 6 | 2019 | 22 | |
| 7 | 2017 | 22 | |
| 8 | 2022 | 21 | |
| 9 | 2013 | 20 | |
| 10 | 2022 | 20 | |
| 11 | 2017 | 18 | |
| 12 | 2018 | 15 | |
| 13 | 2021 | 15 | |
| 14 | 2019 | 15 | |
| 15 | 2023 | 13 | |
| 16 | 2021 | 13 | |
| 17 | 2021 | 12 | |
| 18 | 2011 | 12 | |
| 19 | 2020 | 10 | |
| 20 | 2022 | 10 |
About Jonas Wixner
Jonas Wixner is a scholar working on Molecular Biology, Epidemiology, Surgery, Genetics and Nephrology, having authored 40 papers that have together received 542 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (36 papers), Neuroendocrine Tumor Research Advances (7 papers), Pancreatitis Pathology and Treatment (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Parathyroid Disorders and Treatments (3 papers) and Dermatological and Skeletal Disorders (2 papers). The work is most often cited by research in Nephrology (89 citations), Molecular Biology (471 citations), Genetics (38 citations), Rheumatology (49 citations) and Cell Biology (47 citations). Jonas Wixner has collaborated with scholars based in Sweden, United States and Italy. Frequent co-authors include Intissar Anan, Ole B. Suhr, Pontus Karling, Konen Obayashi, Björn Pilebro, Sadahisa Okamoto, Styrbjörn Friman, Bo-Göran Ericzon, Makoto Uchino and Onur N. Karayal. Their work appears in journals such as Amyloid, Orphanet Journal of Rare Diseases, Neurogastroenterology & Motility, PLoS ONE and Scandinavian Journal of Clinical and Laboratory Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.